NCT05311904View on ClinicalTrials.gov

Efficacy and Safety of Vaccination Against COVID-19 in Neuromuscular Patients

CompletedOBSERVATIONAL
Enrollment

1,388

Participants

Timeline

Start Date

March 11, 2021

Primary Completion Date

February 3, 2023

Study Completion Date

February 3, 2023

Conditions
Neuromuscular Diseases
Interventions
OTHER

Survey

1 initial questionnaire and 1 monthly follow-up questionnaire for 11 months

Trial Locations (1)

33076

CHU de Bordeaux, Bordeaux

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT05311904 - Efficacy and Safety of Vaccination Against COVID-19 in Neuromuscular Patients | Biotech Hunter | Biotech Hunter